Electrophysiological evidence for the implication of cholecystokinin in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 353, Issue 4, 1996, Pages 382-390

  Gronier, Benjamin ^a   Debonnel, Guy ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cholecystokinin; Cl 988; Electrophysiology; Hippocampus; NMDA receptors; Sigma receptors; SR 27897

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CL 988; IGMESINE; LINTITRIPT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PENTAZOCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ELECTROPHYSIOLOGY; HIPPOCAMPUS; MALE; MICROIONTOPHORESIS; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; RAT;

ANIMALS; CHOLECYSTOKININ; CINNAMATES; CYCLOPROPANES; DRUG SYNERGISM; ELECTROPHYSIOLOGY; HIPPOCAMPUS; HORMONE ANTAGONISTS; INDOLEACETIC ACIDS; MALE; N-METHYLASPARTATE; PENTAZOCINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; SINCALIDE; THIAZOLES;

EID: 0029870020     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Akaike A, Tamura Y, Sato Y, Ozaki, Matsuoka R, Miura S, Yoshinaga T (1991) Cholecystokinin-induced protection of cultured cortical neurons against glutamate neurotoxicity. Brain Res 557:303-307
2. Albrecht D, Müller R, Zippel U, Gabriel HJ, Henklein P, Davidowa H (1994) Cholecytokinin-induced activity changes of dorsal lateral geniculate in the rat. Neuroscience 59:953-960.
3. Anis A, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics ketamine and phencyclidine selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. J Pharmacol Exp Ther 79:565-575
4. Bekenstein JW, Bennett JP, Wooten GF, Lothman EW (1990) Autoradiographic Evidence That NMDA receptor-coupled channels are located postsynaptically and not presynaptically in the perforant path-dentate granule cell system of the rat hippocampal formation. Brain Res 514:334-342
5. Bergeron R, de Montigny C, Debonnel G. (1995) Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate. Naunyn-Schmiedeberg's Arch Pharmacol 351:252-260
6. Boden PR, Woodruff GN, Pinnock RD (1991) Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain. Br J Pharmacol 102:635-638
7. Debonnel G, Monnet FP, de Montigny C (1990) Further evidence for the modulation of the excitatory effect of NMDA by sigma receptor ligands. FASEB J 4:A330
8. 3 regions of dorsal hippocampus:effect of mossy fiber lesioning. Neuroscience, in press
9. Greenwood R, Godar SE, Reaves TE, Hayward JN (1981) Cholecystokinin in hippocampal pathways. J Comp Neurol 203:335-350
10. 3 pyramidal neurons:An in vivo electrophysiological study in the rat. Synapse 21:158-168
11. Gué M, Junien JL, Del Rio C, Bueno L (1992) Neuropeptide Y and sigma ligand (JO 1784) suppress stress-induced colonic motor disturbances in rats through sigma and cholecystokinin receptors. J Pharmacol Exp Ther 261:850-855
12. A receptors. Eur J Pharmacol 232:13-19
13. 3H] -3-(3-Hydroxyphenyl)-N-(1-propyl) piperidine. J Neurosci 6:1757-1770
14. Hill DR, Campbell NJ, Shaw TM, Woodruff GN (1987) Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in the rat CNS using highly selective nonpeptide CCK antagonists. J Neurosci 7:2967-2976
15. Hill DR, Woodruff GN (1990) Differentiation of Central Cholecystokinin Receptor Binding Sites Using the Non-Peptide Antagonists mK-329 and L-365, 260. Brain Res 526:276-283
16. Honda T, Wada E, Battey JF, Wank SA (1993) Differential gene expression of CCK-A and CCK-B receptors in the rat brain. Mol Cell Neurosci 4:143-154
17. Hughes J, Boden P, Costall B, Domeney A, Kelly E, Horwell D, Hunter JC, Pinnock RD, Woodruff GN (1990) Development of a novel class of selective cholecystokinin type receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA 87:6728-6732
18. Jorgensen MB, Diemer NH (1982) Selective neuron loss after cerebral ischemia in the rat:Possible role of transmitter glutamate. Acta Neurol Scand 66:536-546
19. Junien JL, Gué M, Pascaud X, Fioramonti J, Bueno L (1990) Selective Stimulation of Colonie Motor Response to a Meal by Sigma-Ligands in Dogs, Gastroenterology 99:684-689
20. Kandel ER, Spencer WA (1961) Electrophysiology of hippocampal neurons. II. After potentials and repetitive firing. J Neurophysiol 24:243-259
21. Maragos WF, Greenamyre JT, Chu DCM, Penney JB, Young AB (1991) A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions. Brain Res 538:36-45
22. Marshall FH, Barnes S, Pinnock RD, Hughes J (1990) Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro. Br J Pharmacol 99:845-848
23. Maurice T, Hiramatsu M, Itoh J, Kameyama T, Hasegawa T, Nabeshima T (1994a) Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res 647:44-56
24. Maurice T, Hiramatsu M, Kameyama T, Hasegawa T, Nabeshima T (1994b) Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice. J Pharmacol Exp Ther 269:665-673
25. Migaud M, Roques BP, Durieux C (1994) Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist, on aspartate and glutamate release from rat hippocampal slices. Neuropharmacology 33:737-743
26. Monnet FP, Debonnel G, Junien JL, de Montigny C (1990) N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur J Pharmacol 179:441-445
27. 3 dorsal hippocampus by sigma ligands. J Pharmacol Exp Ther 261:123-130
28. Monnet FP, Debonnel G, Bergeron R, Gronier B, de Montigny C (1994) The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussis toxin. Br J Pharmacol 112:709-715
29. Nunzi MG, Gorio A, Milan F, Freund TF, Somogy P, Smith AD (1985) Cholecystokinin immunoreactive cells form symmetrical contacts with pyramidal and non pyramidal neurons in the hippocampus. J Comp Neurol 237:485-505
30. Pascaud X, Defaux JP, Rozé C, Junien JL (1990) Effect of selective sigma ligands on duodenal alkaline secretion in the rat. J Pharmacol Exp Ther 255:1354-1359
31. Peinado JM, Myers RD (1988) Cortical amino acid neurotransmitter release is altered by CCK perfused in frontal region of unrestrained aged rates. Peptides 9:631-636
32. Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Taylor DP (1992) Classification of sigma binding sites:A proposal. Kamenka JM, Domino FF (eds) In:Multiple sigma and PCP receptor ligands:mechanisms for neuromodulation and neuroprotection? NPP Books. Ann Arbor, pp 927-933
33. Roman FJ, Pascaud X, Martin B, Vauche D, Junien JL (1990) JO-1784, a potent and selective ligand for rat and mouse brain sigma sites. J Pharm Pharmacol 42:439-440
34. Steinfels GF, Alberici GP, Tarn SW, Cook L (1988) Biochemical, behavioral, and electrophysiological actions of the sigma ligand (+)-pentazocine. Neuropsychopharmacology 1:321-327
35. Takashima A, Maeda Y, Itoh S (1990) Effect of caerulein on decreased latency of passive avoidance response in rats treated with NMDA receptor antagonists. Neurol Res 11:1263-1267
36. Tamura Y, Sato Y, Akaike A, Shiomi H (1992) Mechanisms of cholecystokinin-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 592:317-325
37. Weber E, Sonders M, Quarum M, McLean S, Pou S, Keana JF (1986) 1,3-Di(2- [5-3H] tolyl) guanidine:a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci USA 83:8784-8788